Jump to content

Talampicillin: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
not fda approved
Vannie227 (talk | contribs)
possible hoax from 2013
Line 41: Line 41:
| StdInChIKey = SOROUYSPFADXSN-SUWVAFIASA-N
| StdInChIKey = SOROUYSPFADXSN-SUWVAFIASA-N
}}
}}
'''Talampicillin''' is a [[beta lactam]] [[antibiotic]] from the [[penicillin]] family. It was made by the [[Germany|German]] scientist Mike Hawk, who comes from the [[Frauenhoffer-Institut]]. It is an acid stable prodrug that was administered orally. It is not approved by the FDA for use in the United States.
'''Talampicillin''' is a [[beta lactam]] [[antibiotic]] from the [[penicillin]] family. It is an acid stable prodrug that was administered orally. It is not approved by the FDA for use in the United States.


==Synthesis==
==Synthesis==

Revision as of 19:13, 28 September 2015

Talampicillin
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 3-oxo-1,3-dihydro-2-benzofuran-1-yl (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.051.194 Edit this at Wikidata
Chemical and physical data
FormulaC24H23N3O6S
Molar mass481.52092 g/mol g·mol−1
3D model (JSmol)
  • O=C(OC2OC(=O)c1ccccc12)[C@@H]4N5C(=O)[C@@H](NC(=O)[C@@H](c3ccccc3)N)[C@H]5SC4(C)C
  • InChI=1S/C24H23N3O6S/c1-24(2)17(22(31)33-23-14-11-7-6-10-13(14)21(30)32-23)27-19(29)16(20(27)34-24)26-18(28)15(25)12-8-4-3-5-9-12/h3-11,15-17,20,23H,25H2,1-2H3,(H,26,28)/t15-,16-,17+,20-,23?/m1/s1 ☒N
  • Key:SOROUYSPFADXSN-SUWVAFIASA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Talampicillin is a beta lactam antibiotic from the penicillin family. It is an acid stable prodrug that was administered orally. It is not approved by the FDA for use in the United States.

Synthesis

Ampicillin remains the penicillin of choice for many infections because of its oral activity and good potency against Gram-negative bacteria. A number of prodrugs have been examined in attempts to improve upon the pharmacodynamic characteristics, and one of these is talampicillin.

Talampicillin synthesis:[1][2][3][4]

One synthesis involved protecting the primary amino group of ampicillin (1) as the enamine with ethyl acetoacetate (2). THis was then esterified by reaction with 3-bromopthalide (3), and the enamine was carefully hydrolyzed with dilute HCl in acetonitrile to produce talampicillin (4).

References

  1. ^ I. Isaka, K. Nakano, T. Kashiwagi, A. Koda, H.Horiguchi, H. Matsui, K. Takahashi and M.Murakami, Chem. and Pharm. Bull., 24, 102 (1976).
  2. ^ J. P. Clayton, M. Cole, S. W. Elson, H. Ferres,J. C. Hanson, L. W. Mizen and R. Sutherland, J.Med. Chem., 19, 1385 (1976).
  3. ^ H. Ferres, M. P. Clayton, DE 2228012; eidem, US 3860579 (1972, 1975 both to Beecham).
  4. ^ See also: M. Murakami et al., US 3951954 (1976 to Yamanouchi).